Share on StockTwits

Shares of POZEN (NASDAQ:POZN) traded down 3.2% during mid-day trading on Monday after an insider sold shares in the company, AnalystRatingsNetwork reports. The company traded as low as $8.73 and last traded at $8.76, with a volume of 192,157 shares. The stock had previously closed at $9.05.

Specifically, CFO William L. Hodges unloaded 9,516 shares of the company’s stock on the open market in a transaction dated Thursday, June 19th. The shares were sold at an average price of $9.05, for a total transaction of $86,119.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Separately, analysts at TheStreet upgraded shares of POZEN from a “sell” rating to a “hold” rating in a research note on Monday, May 12th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. POZEN has an average rating of “Hold” and a consensus price target of $9.92.

The stock has a 50-day moving average of $8.64 and a 200-day moving average of $8.48. The company’s market cap is $270.6 million.

POZEN (NASDAQ:POZN) last announced its earnings results on Thursday, May 8th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.13. The company had revenue of $7.55 million for the quarter, compared to the consensus estimate of $5.50 million. During the same quarter in the previous year, the company posted ($0.19) earnings per share. The company’s revenue for the quarter was up 433.5% on a year-over-year basis. Analysts expect that POZEN will post $0.58 EPS for the current fiscal year.

POZEN Inc (NASDAQ:POZN), is a pharmaceutical company focused on transforming medicine.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.